Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deeply invasive candidiasis.

Luis Ostrosky-Zeichner1, John H Rex, John Bennett

  • 1Division of Infectious Diseases, University of Texas-Houston Medical School, 6431 Fannin, JFB 1.728, Houston, TX 77030, USA. Luis.Ostrosky-Zeichner@uth.tmc.edu

Infectious Disease Clinics of North America
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer.

NPJ breast cancer·2026
Same author

A multifaceted antimicrobial stewardship intervention to improve antibiotic utilization and prescribing for sinusitis in a large primary care network.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Cryptococcal Meningitis: Comparison of Short- (≤ 1 Week) Versus Longer-duration (> 1 Week) Liposomal Amphotericin B Induction Therapy and Factors Associated With Clinical Outcomes in HIV and Non-HIV Patients.

Open forum infectious diseases·2026
Same author

Increasing threat to the healthcare setting: Candida auris.

Current opinion in infectious diseases·2026
Same author

Postoperative drain fluid amylase as an adjunctive marker of uncontained esophageal leaks in children.

Pediatric surgery international·2026
Same author

Telework and Employee Well-Being During the COVID-19 Pandemic: A Two-Wave Survey of Employees at a Texas Health Sciences University.

Archivos de prevencion de riesgos laborales·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Invasive candidiasis is increasing due to immunocompromised patients and advanced medical procedures. Azole therapy is emerging as a safer and effective alternative to amphotericin B for severe infections.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • Invasive candidiasis incidence is rising globally.
  • Increasing numbers of immunocompromised patients and invasive medical technologies contribute to this trend.
  • Candida species recovery from multiple sites in critically ill patients warrants investigation for disseminated disease.

Purpose of the Study:

  • To review the current understanding and management of invasive candidiasis.
  • To compare the efficacy and safety of amphotericin B and azole therapies.
  • To highlight the importance of species identification and antifungal susceptibility testing.

Main Methods:

  • Literature review of invasive candidiasis.
  • Analysis of treatment guidelines and clinical evidence.

Related Experiment Videos

  • Comparison of therapeutic outcomes for amphotericin B and azole antifungals.

    • Main Results:

    • Amphotericin B remains a common initial therapy for severe, life-threatening invasive candidiasis.
    • Azole therapy demonstrates comparable efficacy to amphotericin B with an improved safety profile.
    • Species identification and susceptibility testing are crucial for guiding appropriate antifungal selection.

    Conclusions:

    • Invasive candidiasis requires prompt diagnosis and tailored treatment.
    • Azole antifungals represent a viable and often preferred alternative to amphotericin B.
    • Multidisciplinary approaches, including surgical intervention, may be necessary for specific invasive candidiasis presentations.